Population
121 men, including a subgroup of 84 men aged 21 to 93 years, as well as patients with recent myocardial…
Design
Cross-sectional
Authors
Loading...
May enable targeted research on lipolytic responses across ages and MI; leaves open clinical utility pending prospective validation.
The study describes a standardized in vitro method to evaluate heparin-activated clearing factor response across different ages and disease states, including recent myocardial infarction.
Saul P. Baker (1957) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: